These findings reveal the complex profile of the T-cell infiltrate within PDAC and indicate dual PD-1 and TIGIT checkpoint blockade as a potential approach to ameliorate T-cell activity in this tumor of unmet need. The gene discussed is TIGIT; the disease is neoplasm.